Volpara Health Technologies Ltd (ASX:VHT) is a ‘MedTech Software as a Service’ company that was founded in 2009 on research conducted at Oxford University. Its software is used by screening clinics to provide feedback on breast density, compression, dose and quality. Its VolparaEnterprise business provides role-specific dashboards and analytics to help technicians, radiologists, hospitals and clinics manage their operations more efficiently.
I really like the look of some high-quality ASX shares that have the potential to create solid long-term returns.
A wide array of different ASX growth shares have been sold off in recent weeks and months. It looks to me like they’re on sale.
I am always trying to find the best ASX shares for long-term success. Stocks that have good growth potential could be ones to watch.
2022 looks like a really good year to look at promising ASX growth shares. Plenty of attractive businesses have seen their share prices drop recently
Artificial intelligence is the future. But that doesn’t mean Appen will be a winner. Here are three reasons why I’m an Appen bear.
ASX growth shares could be the perfect place to find some long-term opportunities in December 2021, like Volpara Health (ASX:VHT).
The Volpara Health Technologies Ltd (ASX:VHT) share price is rising after the healthcare business released its HY22 result.
This article is about 2 game-changing ASX shares that I’d buy today. One of them is Pushpay Holdings Ltd (ASX:PPH).
If I had $5,000 to invest into ASX tech shares, it’d be an exciting prospect. One idea is Temple & Webster Group Ltd (ASX:TPW).
